-+ 0.00%
-+ 0.00%
-+ 0.00%

DiagnosTear submits FDA pre-submission request for TeaRx Red Eye diagnostic test

PUBT·09/03/2026 11:03:15
Listen to the news
DiagnosTear submits FDA pre-submission request for TeaRx Red Eye diagnostic test
  • DiagnosTear filed an FDA pre-submission request for its TeaRx Red Eye point-of-care diagnostic test.
  • Filing seeks FDA feedback on the U.S. regulatory pathway and supporting data plan.
  • TeaRx aims to help clinicians distinguish major red-eye causes to guide treatment decisions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Diagnostear Technologies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609030700NEWSFILECNPR____20260903_312722_1) on September 03, 2026, and is solely responsible for the information contained therein.